ExcellaBio LLC
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients (NCT03342417) | ExcellaBio LLC | 2018-02-14 |
Track ExcellaBio LLC automatically
Every clearance here is in the API, with alerts when new ones post.